dual PPAR alpha/gamma agonists (Bayer)

N/A

Report date: 2025/03/18 20:00:05
NME

Base Information

Drug Namedual PPAR alpha/gamma agonists (Bayer)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsPeroxisome proliferator-activated receptor α agonists
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor α
Therapy Area/IndicationsHyperglycemiaCardiovascular Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBayer AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBayer AG
Active IndicationsN/A
Inactive IndicationsHyperglycemiaCardiovascular Diseases

Other Information

ATC CodeN/A
Related LinksN/A